Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04247503 · ClinicalTrials.gov registry record
Cohort Study of Pancreatic Cancer Risk
A clinical trial of Familial Pancreatic Cancer, sponsored by Mayo Clinic.
- Active
- Registry status
- 419
- Enrollment target
- 1
- Study location
NCT04247503 is a study of Familial Pancreatic Cancer that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 419 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04247503, a study of Familial Pancreatic Cancer, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 419 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to develop a cohort of individuals without pancreatic cancer, but who are at increased risk of developing it due to family history or genetic predisposition. These high-risk individuals will be asked to provide baseline and annual (serial) follow-up blood samples for the duration of the study funding. \[Blood collection was discontinued August 2025.\] Mayo Clinic is part of a national Pancreatic Cancer Detection Consortium (PCDC) which aims to establish a high-risk cohort with the goal of validating blood biomarkers (discovered/developed outside of this protocol) using the samples collected serially (annually) that predict or detect pancreatic cancer prior to clinical diagnosis.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 419 participants |
| Start Date | 2019-12-11 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04247503
The ClinicalTrials.gov registry entry for NCT04247503 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 419 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Familial Pancreatic Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT04247503 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04247503 about?
NCT04247503 is a clinical study titled "Cohort Study of Pancreatic Cancer Risk". This study is designed to develop a cohort of individuals without pancreatic cancer, but who are at increased risk of developing it due to family history or genetic predisposition. These high-risk individuals will be asked to provide baseline and annual (serial) follow-up blood samples for the durat...
What is the current status of trial NCT04247503?
This trial is currently active not recruiting. The enrollment target is 419 participants. The study started on 2019-12-11. Estimated completion is 2027-12-31.
What conditions does trial NCT04247503 study?
This clinical trial studies the following conditions: Familial Pancreatic Cancer.
Who is sponsoring clinical trial NCT04247503?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04247503 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Familial Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.